Clinical Trials
62 trialsTesting the Addition of Activity Monitoring With a Wearable Electronic Device to Improve Patient Care During Treatment for Lung Cancer
NRG Oncology
Apricity CARE to Improve ICI Outcomes of Ethnic/Racial Minority NSCLC Patients
Columbia University
GT201 Injection in Combination With Teraplizumab Injection for Treatment of Patients With Non-small Cell Lung Cancer
Grit Biotechnology
Exercise as Maintenance Therapy in Advanced Lung Cancer
Indiana University
CONCORDE
Centre Oscar Lambret
Treatment of Multifocal Lung Adenocarcinoma
Mayo Clinic
The Safety and Feasibility of Costal Bone Marrow Aspiration During Thoracic Surgery
Universitair Ziekenhuis Brussel
TESTING
Abramson Cancer Center at Penn Medicine
Liquid Biopsy to Reduce Time to Treatment for Advanced Nonsquamous NSCLC Diagnosed at Outside Sites
Case Comprehensive Cancer Center
TRANSLATE
Pfizer
Exhaled Breath Analysis to Predict Risk of Symptomatic Pneumonitis
Wake Forest University Health Sciences
Early Response Evaluation in NSCLC Patients Treated With Immunotherapy
The Netherlands Cancer Institute
Medical Nutrition Therapy or Standard Care in Treating Patients With Lung Cancer, Pancreatic Cancer, or Stage III or Stage IV Prostate Cancer
Rutgers, The State University of New Jersey
BNT001
Jonsson Comprehensive Cancer Center
Bronchoscopic Laser Ablation of Peripheral Lung Tumors
M.D. Anderson Cancer Center
NAC-PNP
Rijnstate Hospital
Immuno-VOC
Hopital Foch
Metabolic and Microbial Profiling of Lung Cancer
Wake Forest University Health Sciences
Feasibility Study of Enhanced MRI for Early Stage Non Small Cell Lung Cancer (NSCLC)
Dana-Farber Cancer Institute
Daily vs. Non-Daily SBRT for NSCLC
University of Florida
Serial [18F]Thymidine (FLT)PET/CT as a Biomarker of Response in Pemetrexed Therapy for Non-Small Cell Lung Cancer
University of Pennsylvania
GFPC_01-14
Centre Leon Berard
SABR
West Virginia University
NEUWAVE Flex Microwave Ablation System in the Ablation of Primary Soft Tissue Lesions of the Lung
Ethicon, Inc.
Gene Expression Levels in Predicting Treatment Response in Patients With Stage IV Non-small Cell Lung Cancer
Barbara Ann Karmanos Cancer Institute
Evaluation of Apricoxib (Selective Cyclooxygenase 2 Inhibition) in Modulating T Regulatory Cells of Patients With Early Stage Non-small Cell Lung Cancer
Jonsson Comprehensive Cancer Center
Fluorine F 18 FEQA in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer and in Healthy Participants
Jonsson Comprehensive Cancer Center
STARS
Accuray Incorporated
CARACTER
Amphia Hospital
Huaier Granule for Prevention of Recurrence and Metastasis of Stage II and III Non-small Cell Lung Cancer (NSCLC)
Qidong Gaitianli Medicines Co., Ltd
Hatha Yoga in Lung Cancer Couples
M.D. Anderson Cancer Center
Trial of Photodynamic Therapy Versus Argon Plasma Coagulation for Lung Cancer With Endobronchial Obstruction
University of Florida
Feasibility Study of the RF Ablation Catheter to Ablate Lung Tumors
Broncus Medical Inc
Bronchoscopy With Bronchoalveolar Lavage in Identifying Biomarkers of Response to Immune Checkpoint Inhibitors in Patients With Non-small Cell or Small Cell Lung Cancer
Vanderbilt-Ingram Cancer Center
Genetic Sequencing-Informed Targeted Therapy in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Fox Chase Cancer Center
Effect of Qigong Therapy in Patients With Advanced Lung and Gastrointestinal Cancer Undergoing Chemotherapy
McGill University
Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma
GlaxoSmithKline
ACRIN6678
American College of Radiology Imaging Network
NSCLC
Wake Forest University Health Sciences
An Outcome Analysis for Stereotactic Body Radiation Therapy (SBRT) Treatment of Non-Small Lung Cancer Patients Using 4D PET/CT With Real-Time Position Management (RPMâ„¢) System and a Concomitant Evaluation of the Impact and Performance Characteristics of the Immobilization System
University of Pittsburgh
Genomic Sequencing in Determining Treatment in Patients With Metastatic Cancer or Cancer That Cannot Be Removed by Surgery
Wake Forest University Health Sciences
Stereotactic Radiosurgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer
Boston Medical Center
Pulmonary Interstitial Lymphography in Early Stage Lung Cancer
Stanford University
The Effect of Berries on Lung Cancer Tumors
University of Louisville
Ketogenic Diet With Chemoradiation for Lung Cancer (KETOLUNG)
University of Iowa
Safety of LEAD Radiotherapy Plus Chemoradiation in Patients With Bulky Stage III Non-Small Cell Lung Cancer
University of Miami
Early Prediction of Pathology Response of Chemoradiotherapy With FLT PET
Columbia University
LU02
University of Florida
Common Safety Follow-up Trial of Tecemotide (L-BLP25)
Merck KGaA, Darmstadt, Germany
Yoga in Improving Quality of Life in Patients With Non-small Cell Lung Cancer Undergoing Treatment
Virginia Commonwealth University